08:00 , Jan 4, 2016 |  BC Week In Review  |  Company News

Biopta, ReproCell deal

Regenerative medicine company ReproCell will acquire drug discovery and research services company Biopta. ReproCell will acquire 50.26% of Biopta’s shares in cash and the remaining stake for ReproCell shares. The companies did not respond to...
07:00 , Aug 12, 2013 |  BC Week In Review  |  Company News

Midatech, Telormedix, Biopta Ltd., Molecular Profiles Ltd., University Hospital Zurich autoimmune news

Telormedix received €1.8 million ($2.3 million) from the EU's Eurostars Programme to coordinate a 23-month consortium aiming to develop new formulations of Telormedix's TMX-302 to treat psoriasis. The consortium will develop new oral and topical...